PMGC HOLDINGS INC. Line of Credit Facility, Annual Principal Payment
PMGC HOLDINGS INC. (ELAB) reported Line of Credit Facility, Annual Principal Payment of $27.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityAnnualPrincipalPayment · last filed 2026-08-14
- PMGC HOLDINGS INC. line of credit facility, annual principal payment for the quarter ending 2026-06-30 was $10.73M.
- PMGC HOLDINGS INC. line of credit facility, annual principal payment for the quarter ending 2026-03-31 was $16.89M.
- PMGC HOLDINGS INC. line of credit facility, annual principal payment for the quarter ending 2025-12-31 was $0.00.
- PMGC HOLDINGS INC. line of credit facility, annual principal payment for fiscal 2025 was $5.00M.
| Period end | Line of Credit Facility, Annual Principal Payment 3 month | Line of Credit Facility, Annual Principal Payment 6 month | Line of Credit Facility, Annual Principal Payment 9 month | Line of Credit Facility, Annual Principal Payment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $27.62M 10-Q · filed 2026-08-14 | $27.62M derived: sum of 3 quarters · filed 2026-08-14 | |
| 2026-03-31 | $16.89M 10-Q · filed 2026-05-15 | $16.89M derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.00M 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $5.00M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |